A detailed history of Deutsche Bank Ag\ transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 112,386 shares of RVMD stock, worth $4.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,386
Previous 91,533 22.78%
Holding current value
$4.87 Million
Previous $3.55 Million 43.36%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.92 - $47.94 $769,892 - $999,692
20,853 Added 22.78%
112,386 $5.09 Million
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $160,585 - $216,743
-5,328 Reduced 5.5%
91,533 $3.55 Million
Q1 2024

May 15, 2024

SELL
$26.56 - $33.55 $557,069 - $703,677
-20,974 Reduced 17.8%
96,861 $3.12 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $1.19 Million - $2.21 Million
64,834 Added 122.33%
117,835 $3.38 Million
Q3 2023

Nov 09, 2023

BUY
$25.17 - $35.05 $160,534 - $223,548
6,378 Added 13.68%
53,001 $1.47 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $1.21 Million - $1.61 Million
-59,654 Reduced 56.13%
46,623 $1.25 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $409,574 - $593,645
19,729 Added 22.8%
106,277 $2.3 Million
Q4 2022

Feb 13, 2023

BUY
$17.68 - $25.53 $72,063 - $104,060
4,076 Added 4.94%
86,548 $2.06 Million
Q3 2022

Nov 14, 2022

SELL
$17.46 - $26.0 $20,829 - $31,018
-1,193 Reduced 1.43%
82,472 $1.63 Million
Q2 2022

Aug 11, 2022

SELL
$14.54 - $27.17 $41,337 - $77,244
-2,843 Reduced 3.29%
83,665 $1.63 Million
Q1 2022

May 13, 2022

SELL
$17.31 - $26.4 $64,999 - $99,132
-3,755 Reduced 4.16%
86,508 $2.21 Million
Q4 2021

Feb 11, 2022

BUY
$24.35 - $33.7 $22,085 - $30,565
907 Added 1.02%
90,263 $2.27 Million
Q3 2021

Nov 04, 2021

SELL
$23.95 - $33.41 $470,114 - $655,804
-19,629 Reduced 18.01%
89,356 $2.46 Million
Q2 2021

Aug 11, 2021

BUY
$29.0 - $47.44 $848,917 - $1.39 Million
29,273 Added 36.72%
108,985 $3.46 Million
Q1 2021

May 13, 2021

BUY
$37.21 - $54.43 $1.71 Million - $2.51 Million
46,045 Added 136.77%
79,712 $3.66 Million
Q4 2020

Feb 16, 2021

BUY
$30.19 - $45.49 $382,386 - $576,176
12,666 Added 60.31%
33,667 $1.33 Million
Q3 2020

Nov 12, 2020

BUY
$22.61 - $34.8 $306,704 - $472,061
13,565 Added 182.42%
21,001 $731,000
Q2 2020

Aug 13, 2020

BUY
$19.65 - $39.34 $49,734 - $99,569
2,531 Added 51.6%
7,436 $235,000
Q1 2020

May 14, 2020

BUY
$20.0 - $34.08 $98,100 - $167,162
4,905 New
4,905 $107,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.